IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 123 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $612,000 | +16.6% | 38,525 | -4.1% | 0.09% | +13.6% |
| Q2 2016 | $525,000 | -11.8% | 40,175 | -26.1% | 0.08% | -15.6% |
| Q1 2016 | $595,000 | -46.2% | 54,375 | -43.0% | 0.10% | -48.4% |
| Q4 2015 | $1,105,000 | +21.3% | 95,375 | +9.0% | 0.19% | +18.5% |
| Q3 2015 | $911,000 | -2.1% | 87,475 | +13.3% | 0.16% | +15.4% |
| Q2 2015 | $931,000 | -12.9% | 77,225 | +15.6% | 0.14% | -10.5% |
| Q1 2015 | $1,069,000 | +14.8% | 66,825 | +10.0% | 0.15% | +12.6% |
| Q4 2014 | $931,000 | +22.5% | 60,775 | +3.6% | 0.14% | +16.4% |
| Q3 2014 | $760,000 | +15.3% | 58,650 | +36.4% | 0.12% | +27.5% |
| Q2 2014 | $659,000 | +33.7% | 43,000 | +7.5% | 0.09% | +23.0% |
| Q1 2014 | $493,000 | +6.2% | 40,000 | 0.0% | 0.07% | -5.1% |
| Q4 2013 | $464,000 | +95.8% | 40,000 | +100.0% | 0.08% | +85.7% |
| Q3 2013 | $237,000 | +19.1% | 20,000 | 0.0% | 0.04% | +40.0% |
| Q2 2013 | $199,000 | – | 20,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |